Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Array BioPharma presents positive Phase 1 clinical data of ARRY-520 KSP inhibitor for multiple myeloma

Array BioPharma presents positive Phase 1 clinical data of ARRY-520 KSP inhibitor for multiple myeloma

Onyx reports encouraging ORR from ongoing Carfilzomib Phase 2 study for multiple myeloma

Onyx reports encouraging ORR from ongoing Carfilzomib Phase 2 study for multiple myeloma

Poniard reports positive data from Phase 3 SPEAR trial of picoplatin for SCLC

Poniard reports positive data from Phase 3 SPEAR trial of picoplatin for SCLC

Phase II study results of pomalidomide, dexamethasone for multiple myeloma presented at ASCO

Phase II study results of pomalidomide, dexamethasone for multiple myeloma presented at ASCO

Alder Biopharmaceuticals reports positive data from ALD518 Phase 2a clinical trial for NSCLC

Alder Biopharmaceuticals reports positive data from ALD518 Phase 2a clinical trial for NSCLC

SOGC wants Canadian women to understand how sexual desire is more than just a feeling

SOGC wants Canadian women to understand how sexual desire is more than just a feeling

NHLBI stops trial evaluating new approach to reduce risk of recurrent stroke in children with sickle cell anemia

NHLBI stops trial evaluating new approach to reduce risk of recurrent stroke in children with sickle cell anemia

Celgene reports initial data from investigator-initiated study of REVLIMID

Celgene reports initial data from investigator-initiated study of REVLIMID

Millennium announces data on VELCADE in treatment of patients with amyloidosis

Millennium announces data on VELCADE in treatment of patients with amyloidosis

Unsatisfactory interactions with physicians affect sickle cell disease patients' trust in medical profession

Unsatisfactory interactions with physicians affect sickle cell disease patients' trust in medical profession

Vandetanib in combination with chemotherapy improves progression-free survival in patients with lung cancer

Vandetanib in combination with chemotherapy improves progression-free survival in patients with lung cancer

Onyx presents interim results of Phase 1b dose-escalation carfilzomib combination trial for multiple myeloma

Onyx presents interim results of Phase 1b dose-escalation carfilzomib combination trial for multiple myeloma

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemotherapy

Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemotherapy

Phase III study of Afinitor tablets in patients with advanced pancreatic NET meets primary endpoint

Phase III study of Afinitor tablets in patients with advanced pancreatic NET meets primary endpoint

Entelos' T1D PhysioLab platform published in Clinical and Experimental Immunology

Entelos' T1D PhysioLab platform published in Clinical and Experimental Immunology

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Allos Therapeutics' FOLOTYN data to be presented at 46th ASCO and 15th EHA Congress

Allos Therapeutics' FOLOTYN data to be presented at 46th ASCO and 15th EHA Congress

EMBL scientists identify two small RNA molecules that ensure red blood cell production

EMBL scientists identify two small RNA molecules that ensure red blood cell production

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.